Knoles
Knoles v. Teva Pharmaceuticals USA, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 MARLESSA KNOLES, Case No. 17-cv-06580-BLF
Plaintiff,
ORDER DISMISSING SECOND
v. AMENDED COMPLAINT AS TO ALL
REMAINING DEFENDANTS; AND
TEVA PHARMACEUTICALS USA, INC.; DISMISSING ACTION WITHOUT
TEVA BRANDED PHARMACEUTICALS PREJUDICE
PRODUCTS R&D, INC.; FEI WOMEN’S
HEALTH LLC; ORTHO-MCNEIL
PHARMACEUTICAL, LLC; and
DURAMED PHARMACEUTICALS,
13 Defendants. 14 15 On October 17, 2019, the Court granted the Teva Defendants’ motion to dismiss the second amended complaint (“SAC”) for lack of personal jurisdiction, without leave to amend. See Order, ECF 81. The Court also ordered Plaintiff to show cause, in writing and on or before October 31, 2019, why the second amended complaint should not be dismissed with respect to the three remaining defendants, FEI Women’s Health LLC, Ortho-McNeil Pharmaceutical, LLC, and Duramed Pharmaceuticals. See Order, ECF 81. The Court stated its view that…